000 01338 a2200349 4500
005 20250515061148.0
264 0 _c20070816
008 200708s 0 0 eng d
022 _a1618-7598
024 7 _a10.1007/s10198-007-0042-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNorman, Richard P A
245 0 0 _aThe cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49.
_h[electronic resource]
260 _bThe European journal of health economics : HEPAC : health economics in prevention and care
_cJun 2007
300 _a137-44 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aBreast Neoplasms
_xdiagnosis
650 0 4 _aCost-Benefit Analysis
650 0 4 _aFemale
650 0 4 _aGenes, BRCA1
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Imaging
_xeconomics
650 0 4 _aMarkov Chains
650 0 4 _aMiddle Aged
650 0 4 _aMutation
_xgenetics
700 1 _aEvans, D Gareth
700 1 _aEaston, Douglas F
700 1 _aYoung, Kenneth C
773 0 _tThe European journal of health economics : HEPAC : health economics in prevention and care
_gvol. 8
_gno. 2
_gp. 137-44
856 4 0 _uhttps://doi.org/10.1007/s10198-007-0042-9
_zAvailable from publisher's website
999 _c16904227
_d16904227